Stock Track | Evolent Health Soars on Bullish Analyst Rating

Stock Track11-11

Shares of Evolent Health Inc. (EVH) surged 5.46% on Friday, November 11th, following a positive analyst rating from Truist Financial. Truist analyst Jailendra Singh assigned a Buy rating on the healthcare services company and raised the price target to $24, citing strong growth prospects.

The bullish rating from Truist appears to be the primary catalyst behind Evolent Health's stock rally. In a research note, Singh highlighted the company's robust pipeline and potential for further market share gains in the rapidly expanding value-based care sector.

While Barclays cut its price target on Evolent Health to $19 from $39, the market seems to have placed greater weight on Truist's optimistic outlook. The stock closed at $32.85, up $1.70 from the previous day's close, as investors cheered the positive analyst commentary.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1121724515?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-11-11 22:35","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1121724515","market":"hk","top_or_hot":-1,"title":"Stock Track | Evolent Health Soars on Bullish Analyst Rating","media":"Stock Track","content":"<p>Shares of Evolent Health Inc. (EVH) surged 5.46% on Friday, November 11th, following a positive analyst rating from Truist Financial. Truist analyst Jailendra Singh assigned a Buy rating on the healthcare services company and raised the price target to $24, citing strong growth prospects.</p>\n\n<p>The bullish rating from Truist appears to be the primary catalyst behind Evolent Health's stock rally. In a research note, Singh highlighted the company's robust pipeline and potential for further market share gains in the rapidly expanding value-based care sector.</p>\n\n<p>While Barclays cut its price target on Evolent Health to $19 from $39, the market seems to have placed greater weight on Truist's optimistic outlook. The stock closed at $32.85, up $1.70 from the previous day's close, as investors cheered the positive analyst commentary.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Evolent Health Soars on Bullish Analyst Rating</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Evolent Health Soars on Bullish Analyst Rating\n</h2>\n\n<h4 class=\"meta\">\n\n2024-11-11 22:35 北京时间&nbsp;&nbsp;&nbsp;<strong>Stock Track</strong>\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Shares of Evolent Health Inc. (EVH) surged 5.46% on Friday, November 11th, following a positive analyst rating from Truist Financial. Truist analyst Jailendra Singh assigned a Buy rating on the ...</p>\n\n<a href=\"\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"EVH","symbol_name":"Evolent Health Inc","start_time":0,"source_url":"","article_id":"1121724515","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1121724515","pubTimestamp":1731335715,"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Shares of Evolent Health Inc.  surged 5.46% on Friday, November 11th, following a positive analyst rating from Truist Financial. Truist analyst Jailendra Singh assigned a Buy rating on the healthcare services company and raised the price target to $24, citing strong growth prospects.The bullish rating from Truist appears to be the primary catalyst behind Evolent Health's stock rally. In a research note, Singh highlighted the company's robust pipeline and potential for further market share gains ","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"EVH":"Evolent Health Inc"},"translate_title":"股票赛道Evolent Health因分析师看涨评级而飙升","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"EVH":1},"content_text":"Shares of Evolent Health Inc. (EVH) surged 5.46% on Friday, November 11th, following a positive analyst rating from Truist Financial. Truist analyst Jailendra Singh assigned a Buy rating on the healthcare services company and raised the price target to $24, citing strong growth prospects.\nThe bullish rating from Truist appears to be the primary catalyst behind Evolent Health's stock rally. In a research note, Singh highlighted the company's robust pipeline and potential for further market share gains in the rapidly expanding value-based care sector.\nWhile Barclays cut its price target on Evolent Health to $19 from $39, the market seems to have placed greater weight on Truist's optimistic outlook. The stock closed at $32.85, up $1.70 from the previous day's close, as investors cheered the positive analyst commentary.","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":0},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1121724515"}